ethyl 2-(5-(4-chlorophenyl)pentyl)oxiran-2-carboxylate has been researched along with Cardiomegaly in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bone, AJ; Koundakjian, PP; Rogers, MP; Sherratt, HS; Turnbull, DM; Younan, SI | 1 |
1 other study(ies) available for ethyl 2-(5-(4-chlorophenyl)pentyl)oxiran-2-carboxylate and Cardiomegaly
Article | Year |
---|---|
Metabolic changes in fed rats caused by chronic administration of ethyl 2[5(4-chlorophenyl)pentyl]oxirane-2-carboxylate, a new hypoglycaemic compound.
Topics: Animals; Body Weight; Carbohydrate Metabolism; Cardiomegaly; Dietary Fats; Epoxy Compounds; Ethers, Cyclic; Fatty Acids; Hypoglycemic Agents; Liver; Male; Microbodies; Muscles; Organ Size; Rats; Rats, Inbred Strains | 1984 |